Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Natera, Inc.
Primary Objectives: * Examine the impact of SIGNATERA™ on adjuvant treatment decisions * Determine the rate of recurrence of patients diagnosed with CRC while asymptomatic using SIGNATERA™ Secondary objectives: * Molecular residual disease clearance as assessed by SIGNATERA™ * Percent of patients undergoing surgery for oligometastatic recurrence * Survival in patients treated with adjuvant versus no adjuvant chemotherapy in patients with SIGNATERA™ negative test results * Overall survival * Impact of SIGNATERA™ test results on patient quality of life
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted